2018
DOI: 10.1016/j.bj.2018.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Computational prediction of vaccine potential epitopes and 3-dimensional structure of XAGE-1b for non-small cell lung cancer immunotherapy

Abstract: BackgroundXAGE-1b is shown to be overexpressed in lung adenocarcinoma and to be a strong immunogenic antigen among non-small cell lung cancer (NSCLC) patients. However, 3D structure of XAGE-1b is not available and its confirmation has not been solved yet.MethodsMultiple sequence alignment was run to select the most reliable templates. Homology modeling technique was performed using computer-based tool to generate 3-dimensional structure models, eight models were generated and assessed on basis of local and glo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 58 publications
0
9
0
Order By: Relevance
“…This includes antigenicity, surface accessibility and hydrophilicity, typical characteristics of linear immunogenic epitopes of antigens [22]. The epitope mapping tools used in this study have previously been used to identify immunogenic sequences of known antigens from infectious agents and cancer biomarkers [23,24]. Its applications ranged from vaccine research to diagnostic tool development, from which the outcomes for the latter is improvement in the sensitivity, specificity, or both in detection of diseases [25][26].…”
Section: Discussionmentioning
confidence: 99%
“…This includes antigenicity, surface accessibility and hydrophilicity, typical characteristics of linear immunogenic epitopes of antigens [22]. The epitope mapping tools used in this study have previously been used to identify immunogenic sequences of known antigens from infectious agents and cancer biomarkers [23,24]. Its applications ranged from vaccine research to diagnostic tool development, from which the outcomes for the latter is improvement in the sensitivity, specificity, or both in detection of diseases [25][26].…”
Section: Discussionmentioning
confidence: 99%
“…XAGE-1b is considered as a tumor serological marker which assisted clinical diagnosis [7,14] . Moreover, signi cant dysregulated levels of XAGE-1b were observed in several tumors [5][6][7][8][9][10][11][12][13][14][15][16][17][18][19]21] . However, XAGE-1b expression in GC and its role in the prognosis of GC patients remain unclear.…”
Section: Discussionmentioning
confidence: 99%
“…The recent advancements in the technological and bioinformatics fields enable computer-based approaches for prediction bioinformatics tools for epitope prediction [ 90 ]; A range of computational methods have been developed for predicting which of an antigen’s residues are likely to form part of a B-cell epitope: computational prediction of vaccine potential epitopes and 3D structure [ 91 ]; an analysis of B-cell epitope discontinuity [ 92 ], B-cell epitope identification and production of neutralizing murine antibodies [ 93 ]; structural analysis of B-cell epitopes in antibody:protein complexes [ 94 ]. In silico peptide development approaches to predict B-cell epitope online analysis resource at IEDB ( www.iedb.org/ ) and http://tools.immuneepitope.org/toolsElliPro/ .…”
Section: Her-2 B-cell Epitope Peptide Vaccines Approaches: Preclinicamentioning
confidence: 99%